The Acid Base Series

EMCrit Podcast – Acid Base Ep. 7 – Bicarb Updates, Quantitative Approach, and Prof. David StoryPodcast 97 – Acid-Base VI – Chloride-Free SodiumPodcast 96 – Acid Base in the Critically Ill – Part V – Enough with the Bicarb AlreadyEMCrit Podcast 50 – Acid Base Part IV – Choose the Solution Based on the ProblemEMCrit Podcast 46 – Acid Base: Part IIIEMCrit Podcast 45 – Acid Base: Part IIEMCrit Podcast 44 – Acid Base: Part I

Time for more discussion of acid-base, a subject you know i obsess about.

Bicar-ICU Trial

* Read the amazing trial by Jaber et al.

* PulmCrit's take

* The Bottom Line

* CCNerd

Keith Corl's Email

Hi Scott,

By now I'm sure you've seen the work from Jaber's group on using bicarb in critically ill academic patients. Obviously there are limitations to the trial, not the least of them a negative primary outcome. And while the study wasn't powered to look a 28 day mortality or 7 day organ failure in those with a AKIN score of 2-3 I am sure many will take this positive secondary finding and run with it.

My biggest criticism was that they didn't break the study down into patients with anion gap metabolic acidosis (AGMA) vs. non-anion gap metabolic acidosis (NAGMA). I'm a big fan of your acid base pods and tend to agree with your take and the Forsythe paper and don't give bicarb to patients with an AGMA. So I went ahead and emailed Jaber and he got back to me. He told me that "90% of the patients enrolled were hyperlactatemic." Moreover, most GI and renal patients with base loss were excluded b.c. bicarb was considered standard care, therefore the "large majority" had an AGMA. Interesting, now I'm second guessing myself and wondering if I should consider bicarb in AKIN patients with a AGMA.

I'm interested to hear your thoughts. I think it would make a great pod or a topic for Josh or Rory.

I hope all is well,

Keith

 

then I bring on Dr. David Story to discuss acid base and a set of posts by Jon-Emile Kenny.

Professor David Story

Head of Anaesthesia, Perioperative and Pain Medicine Unit (APPMU), Melbourne Medical School, University of Melbourne; Director, Melbourne Clinical and Translational Sciences (MCATS) research platform

Jon-Emile Kenny Lactate Debate Posts

* Part 1

* Part 2

Gamblegram

go to acidbase.